Product Information
MYCOPHENOLATE 250 MG CAPSULE is a generic product labeled by Strides Pharma Inc., priced at $0.1382 per EA under NDC 64380072607. Its NADAC has been published 633 times since Aug 20, 2014.
FDA first approved this application on Jun 10, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380072607
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MYCOPHENOLATE MOFETILApproval Type
Generic (ANDA)
FDA Application
ANDA090055FDA Approved
6/10/2010
TE Code
AB
On Market Since
11/6/2010
Pharmacological Classes
Price Statistics
The NADAC for MYCOPHENOLATE 250 MG CAPSULE has been published 633 times since Aug 20, 2014, and over the history we have for it it has declined 45.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1382 per EA |
|---|---|
| All-time high | $0.2812 (Oct 15, 2014) |
| All-time low | $0.1331 (Sep 17, 2025) |
| 52-week high | $0.1452 |
| 52-week low | $0.1331 |
| Median price | $0.1937 |
| Average price | $0.1955 |
| Largest weekly change | -32.7% (Jul 17, 2024) |
| Weeks tracked | 633 |
| Tracking since | Aug 20, 2014 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strides Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mycophenolate mofetil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimetabolite Immunosuppressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MYCOPHENOLATE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MYCOPHENOLATE 250 MG CAPSULE, manufactured by Strides Pharma Inc., is $0.1382 per EA (NDC 64380072607), effective Sep 30, 2026.
How has the price of MYCOPHENOLATE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MYCOPHENOLATE 250 MG CAPSULE has declined 45.5%. It has been tracked across 633 weekly CMS publications since Aug 20, 2014.
What are the highest and lowest recorded NADAC prices for MYCOPHENOLATE 250 MG CAPSULE?
Since Aug 20, 2014, the NADAC for MYCOPHENOLATE 250 MG CAPSULE has ranged from a low of $0.1331 (Sep 17, 2025) to a high of $0.2812 (Oct 15, 2014), with a median of $0.1937 per EA.
Are there cheaper alternatives to MYCOPHENOLATE 250 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MYCOPHENOLATE 250 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures MYCOPHENOLATE 250 MG CAPSULE?
MYCOPHENOLATE 250 MG CAPSULE (NDC 64380072607) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.